BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med 2021. [PMID: 34125572 DOI: 10.7326/L21-0282] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 34.0] [Reference Citation Analysis]
Number Citing Articles
1 Kant S, Azar A, Geetha D. Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2021:S0085-2538(21)01074-7. [PMID: 34822874 DOI: 10.1016/j.kint.2021.11.012] [Reference Citation Analysis]
2 Cholankeril G, Al-Hillan A, Tarlow B, Abrams D, Jacobs JS, Flores NP, Rana A, Kanwal F, Goss JA. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients. Liver Transpl 2021. [PMID: 34724328 DOI: 10.1002/lt.26351] [Reference Citation Analysis]
3 Furian L, Russo FP, Zaza G, Burra P, Hartzell S, Bizzaro D, Di Bello M, Di Bella C, Nuzzolese E, Agnolon C, Florman S, Rana M, Lee J, Kim Y, Maggiore U, Maltzman JS, Cravedi P. Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients. Front Immunol 2022;13:853682. [DOI: 10.3389/fimmu.2022.853682] [Reference Citation Analysis]
4 Chang KM, Berlinrut I, Wallach FR. A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient. Transpl Infect Dis 2021;:e13710. [PMID: 34339083 DOI: 10.1111/tid.13710] [Reference Citation Analysis]
5 Chauhan M, Nzeako I, Li F, Thuluvath PJ. Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases. Ann Hepatol 2022;:100702. [PMID: 35338012 DOI: 10.1016/j.aohep.2022.100702] [Reference Citation Analysis]
6 Giannella M, Righi E, Pascale R, Rinaldi M, Caroccia N, Gamberini C, Palacios-baena ZR, Caponcello G, Morelli MC, Tamè M, Busutti M, Comai G, Potena L, Salvaterra E, Feltrin G, Cillo U, Gerosa G, Cananzi M, Piano S, Benetti E, Burra P, Loy M, Furian L, Zaza G, Onorati F, Carraro A, Gastaldon F, Nordio M, Kumar-singh S, Abedini M, Boffetta P, Rodríguez-baño J, Lazzarotto T, Viale P, Tacconelli E; on behalf of The ORCHESTRA Study Group Workpackage. Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort. Microorganisms 2022;10:1021. [DOI: 10.3390/microorganisms10051021] [Reference Citation Analysis]
7 Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis. Eur J Cancer 2021:S0959-8049(21)01168-0. [PMID: 34794855 DOI: 10.1016/j.ejca.2021.10.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bensouna I, Caudwell V, Kubab S, Acquaviva S, Pardon A, Vittoz N, Bozman DF, Hanafi L, Faucon AL, Housset P. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis. Am J Kidney Dis 2021:S0272-6386(21)00833-7. [PMID: 34508833 DOI: 10.1053/j.ajkd.2021.08.005] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Fernández-ruiz M. COVID-19 en receptores de trasplante renal: ¿qué hemos aprendido tras 18 meses de pandemia? Enferm Nefrol 2021;24:219-31. [DOI: 10.37551/s2254-28842021020] [Reference Citation Analysis]
10 Pozdnyakova V, Botwin GJ, Sobhani K, Prostko J, Braun J, Mcgovern DPB, Melmed GY, Appel K, Banty A, Feldman E, Ha C, Kumar R, Lee S, Rabizadeh S, Stein T, Syal G, Targan S, Vasiliauskas E, Ziring D, Debbas P, Hampton M, Mengesha E, Stewart JL, Frias EC, Cheng S, Ebinger J, Figueiredo JC, Boland B, Charabaty A, Chiorean M, Cohen E, Flynn A, Valentine J, Fudman D, Horizon A, Hou J, Hwang C, Lazarev M, Lum D, Fausel R, Reddy S, Mattar M, Metwally M, Ostrov A, Parekh N, Raffals L, Sheibani S, Siegel C, Wolf D, Younes Z. Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease. Gastroenterology 2021;161:2041-2043.e1. [PMID: 34391771 DOI: 10.1053/j.gastro.2021.08.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
11 Windpessl M, Heine GH, Becker SL, Scheuer AL, Sester M, Kronbichler A. [The impact of immunosuppression and chronic kidney disease on immunogenicity of COVID-19 vaccines]. Dtsch Med Wochenschr 2021;146:1277-82. [PMID: 34553353 DOI: 10.1055/a-1550-7288] [Reference Citation Analysis]
12 Russo G, Lai Q, Poli L, Perrone MP, Gaeta A, Rossi M, Mastroianni CM, Garofalo M, Pretagostini R. SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications. Clin Transplant 2021;:e14495. [PMID: 34569101 DOI: 10.1111/ctr.14495] [Reference Citation Analysis]
13 Bartelt L, van Duin D. An Overview of COVID-19 in solid organ transplantation. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.02.005] [Reference Citation Analysis]
14 Guarino M, Cossiga V, Esposito I, Alessandro F, Morisco F. Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: the debate is open! J Hepatol 2021:S0168-8278(21)01961-9. [PMID: 34358567 DOI: 10.1016/j.jhep.2021.07.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Sun J, Patel RC, Zheng Q, Madhira V, Olex AL, Islam JY, French E, Chiang TP, Akselrod H, Moffitt R, Alexander GC, Andersen KM, Vinson AJ, Brown TT, Chute CG, Crandall KA, Franceschini N, Mannon RB, Kirk GD; National COVID Cohort Collaborative (N3C) Consortium. COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study. medRxiv 2021:2021. [PMID: 34341798 DOI: 10.1101/2021.07.26.21261028] [Reference Citation Analysis]
16 Charmetant X, Espi M, Benotmane I, Barateau V, Heibel F, Buron F, Gautier-Vargas G, Delafosse M, Perrin P, Koenig A, Cognard N, Levi C, Gallais F, Manière L, Rossolillo P, Soulier E, Pierre F, Ovize A, Morelon E, Defrance T, Fafi-Kremer S, Caillard S, Thaunat O. Infection or a third dose of mRNA vaccine elicit neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients. Sci Transl Med 2022;:eabl6141. [PMID: 35103481 DOI: 10.1126/scitranslmed.abl6141] [Reference Citation Analysis]
17 Sun J, Zheng Q, Madhira V, Olex AL, Anzalone AJ, Vinson A, Singh JA, French E, Abraham AG, Mathew J, Safdar N, Agarwal G, Fitzgerald KC, Singh N, Topaloglu U, Chute CG, Mannon RB, Kirk GD, Patel RC; National COVID Cohort Collaborative (N3C) Consortium. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US. JAMA Intern Med 2021. [PMID: 34962505 DOI: 10.1001/jamainternmed.2021.7024] [Reference Citation Analysis]
18 Aikawa NE, Kupa LDVK, Medeiros-ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, Rojo PT, Pereira RMR, Shinjo SK, Sampaio-barros PD, Andrade DCO, Halpern ASR, Fuller R, Souza FHC, Guedes LKN, Assad APL, Moraes JCBD, Lopes MRU, Martins VADO, Betancourt L, Ribeiro CT, Sales LP, Bertoglio IM, Bonoldi VLN, Mello RLP, Balbi GGM, Sartori AMC, Antonangelo L, Silva CA, Bonfa E. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Ann Rheum Dis. [DOI: 10.1136/annrheumdis-2021-222096] [Reference Citation Analysis]
19 Bonelli M, Mrak D, Tobudic S, Sieghart D, Koblischke M, Mandl P, Kornek B, Simader E, Radner H, Perkmann T, Haslacher H, Mayer M, Hofer P, Redlich K, Husar-Memmer E, Fritsch-Stork R, Thalhammer R, Stiasny K, Winkler S, Smolen JS, Aberle JH, Zeitlinger M, Heinz LX, Aletaha D. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial. Ann Rheum Dis 2022:annrheumdis-2021-221558. [PMID: 35027397 DOI: 10.1136/annrheumdis-2021-221558] [Reference Citation Analysis]
20 Yahav D, Rahamimov R, Mashraki T, Ben-Dor N, Steinmetz T, Agur T, Zingerman B, Herman-Edelstein M, Lichtenberg S, Ben-Zvi H, Bar-Haim E, Cohen H, Rotem S, Elia U, Margalit I, Zvi BR. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study. Transpl Int 2022;35:10204. [PMID: 35529596 DOI: 10.3389/ti.2022.10204] [Reference Citation Analysis]
21 Reimann P, Ulmer H, Mutschlechner B, Benda M, Severgnini L, Volgger A, Lang T, Atzl M, Huynh M, Gasser K, Grabher C, Mink S, Fraunberger P, Petrausch U, Hartmann B, Winder T. Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response. Br J Haematol 2021. [PMID: 34872162 DOI: 10.1111/bjh.17982] [Reference Citation Analysis]
22 Manothummetha K, Chuleerarux N, Sanguankeo A, Kates OS, Hirankarn N, Thongkam A, Dioverti-Prono MV, Torvorapanit P, Langsiri N, Worasilchai N, Moonla C, Plongla R, Garneau WM, Chindamporn A, Nissaisorakarn P, Thaniyavarn T, Nematollahi S, Permpalung N. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis. JAMA Netw Open 2022;5:e226822. [PMID: 35412626 DOI: 10.1001/jamanetworkopen.2022.6822] [Reference Citation Analysis]
23 Peled Y, Ram E, Lavee J, Segev A, Matezki S, Wieder-Finesod A, Halperin R, Mandelboim M, Indenbaum V, Levy I, Sternik L, Raanani E, Afek A, Kreiss Y, Lustig Y, Rahav G. Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience. J Heart Lung Transplant 2021:S1053-2498(21)02481-5. [PMID: 34565682 DOI: 10.1016/j.healun.2021.08.010] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Frick DN. A transplant recipient's pandemic perspective. Transpl Infect Dis 2021;23:e13738. [PMID: 34590768 DOI: 10.1111/tid.13738] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mamez AC, Pradier A, Giannotti F, Petitpas A, Urdiola MF, Vu DL, Masouridi-Levrat S, Morin S, Dantin C, Clerc-Renaud D, Eberhardt CS, Kaiser L, Simonetta F, Chalandon Y. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2021. [PMID: 34584239 DOI: 10.1038/s41409-021-01466-9] [Reference Citation Analysis]
26 Sakai A, Morishita T, Matsunami H. Antibody Response After a Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Liver Transplant Recipients. Transpl Int 2022;35:10321. [DOI: 10.3389/ti.2022.10321] [Reference Citation Analysis]
27 Mair MJ, Berger JM, Mitterer M, Gansterer M, Bathke AC, Trutschnig W, Berghoff AS, Perkmann T, Haslacher H, Lamm WW, Raderer M, Tobudic S, Fuereder T, Buratti T, Fong D, Preusser M. Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study. European Journal of Cancer 2022. [DOI: 10.1016/j.ejca.2022.01.019] [Reference Citation Analysis]
28 Agha ME, Blake M, Chilleo C, Wells A, Haidar G. Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era. Open Forum Infect Dis 2021;8:ofab353. [PMID: 34337100 DOI: 10.1093/ofid/ofab353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Hill JA, Ujjani CS, Greninger AL, Shadman M, Gopal AK. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient. Cancer Cell 2021;39:1037-8. [PMID: 34242571 DOI: 10.1016/j.ccell.2021.06.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Alukal JJ, Naqvi HA, Thuluvath PJ. Vaccination in Chronic Liver Disease: An Update. J Clin Exp Hepatol 2021. [PMID: 34975241 DOI: 10.1016/j.jceh.2021.12.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Schoemans H, Ljungman P. One step at a time. Blood 2021;138:1208-9. [PMID: 34618004 DOI: 10.1182/blood.2021013434] [Reference Citation Analysis]
32 Dulek DE, Ardura MI, Green M, Michaels MG, Chaudhuri A, Vasquez L, Danziger-Isakov L, Posfay-Barbe KM, McCulloch MI, L'Huillier AG, Benden C. Update on COVID-19 vaccination in pediatric solid organ transplant recipients. Pediatr Transplant 2022;:e14235. [PMID: 35060251 DOI: 10.1111/petr.14235] [Reference Citation Analysis]
33 Spinner JA, Julien CL, Olayinka L, Dreyer WJ, Bocchini CE, Munoz FM, Devaraj S. SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report. J Heart Lung Transplant 2021:S1053-2498(21)02578-X. [PMID: 34911654 DOI: 10.1016/j.healun.2021.11.001] [Reference Citation Analysis]
34 Alejo JL, Mitchell J, Chiang TP, Abedon AT, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation 2021;105:e280-1. [PMID: 34428188 DOI: 10.1097/TP.0000000000003934] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Golshani M, Hrdý J. Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination. Vaccines 2022;10:279. [DOI: 10.3390/vaccines10020279] [Reference Citation Analysis]
36 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Corti C, Antonarelli G, Scotté F, Spano JP, Barrière J, Michot JM, André F, Curigliano G. Seroconversion rate after vaccination against COVID-19 in cancer patients-a systematic review. Ann Oncol 2021:S0923-7534(21)04550-6. [PMID: 34718117 DOI: 10.1016/j.annonc.2021.10.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, Yousaf Z, Seboka BT, Ullah I, Lin CY, Pakpour AH. COVID-19 Vaccine Hesitancy in the United States: A Systematic Review. Front Public Health 2021;9:770985. [PMID: 34888288 DOI: 10.3389/fpubh.2021.770985] [Reference Citation Analysis]
39 Kute VB, Shah N, Meshram HS, Banerjee S, Chauhan S, Dave R, Desai S, Patel H, Mishra V. Safety and efficacy of Oxford vaccine in kidney transplant recipients: A single-center prospective analysis from India. Nephrology (Carlton) 2021. [PMID: 34927312 DOI: 10.1111/nep.14012] [Reference Citation Analysis]
40 Tcheou J, Raskin A, Singh G, Kawabata H, Bielak D, Sun W, González-Domínguez I, Sather DN, García-Sastre A, Palese P, Krammer F, Carreño JM. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats. Front Immunol 2021;12:791764. [PMID: 34868082 DOI: 10.3389/fimmu.2021.791764] [Reference Citation Analysis]
41 Yanis A, Haddadin Z, Spieker AJ, Waqfi D, Rankin DA, Talj R, Thomas L, Birdwell KA, Ezzell L, Blair M, Eason J, Varjabedian R, Warren CM, Nochowicz CH, Olson EC, Simmons JD, Yoder S, Guy M, Thomsen I, Chappell JD, Kalams SA, Halasa NB. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls. Transpl Infect Dis 2021;:e13772. [PMID: 34905653 DOI: 10.1111/tid.13772] [Reference Citation Analysis]
42 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Reference Citation Analysis]
43 Toniutto P, Aghemo A, Grossi P, Burra P; Permanent Transplant Commission of the Italian Association for the Study of the Liver. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients. Dig Liver Dis 2021:S1590-8658(21)00387-X. [PMID: 34393073 DOI: 10.1016/j.dld.2021.07.019] [Reference Citation Analysis]
44 Loconsole D, Stea ED, Sallustio A, Fontò G, Pronzo V, Simone S, Centrone F, Accogli M, Gesualdo L, Chironna M. Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients. Vaccines (Basel) 2021;9:806. [PMID: 34451931 DOI: 10.3390/vaccines9080806] [Reference Citation Analysis]
45 Peluso MJ, Donatelli J, Henrich TJ. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. Transl Res 2021:S1931-5244(21)00269-3. [PMID: 34780969 DOI: 10.1016/j.trsl.2021.11.006] [Reference Citation Analysis]
46 Massa F, Cremoni M, Gérard A, Grabsi H, Rogier L, Blois M, Couzin C, Hassen NB, Rouleau M, Barbosa S, Martinuzzi E, Fayada J, Bernard G, Favre G, Hofman P, Esnault VLM, Czerkinsky C, Seitz-Polski B, Glaichenhaus N, Sicard A. Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients. EBioMedicine 2021;73:103679. [PMID: 34763205 DOI: 10.1016/j.ebiom.2021.103679] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Ben-Dov IZ, Tzukert K, Aharon M, Pri-Chen H, Oster Y, Oiknine-Djian E, Wolf DG, Dranitzki Elhalel M. Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients. J Nephrol 2022. [PMID: 35038151 DOI: 10.1007/s40620-021-01235-3] [Reference Citation Analysis]
48 Nazaruk P, Monticolo M, Jędrzejczak AM, Krata N, Moszczuk B, Sańko-Resmer J, Pilecki T, Urbanowicz A, Florczak M, Pączek L, Foroncewicz B, Mucha K. Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients-Is It Related to Immunosuppression Only? Vaccines (Basel) 2021;9:1454. [PMID: 34960200 DOI: 10.3390/vaccines9121454] [Reference Citation Analysis]
49 Motos A, López-Gavín A, Riera J, Ceccato A, Fernández-Barat L, Bermejo-Martin JF, Ferrer R, de Gonzalo-Calvo D, Menéndez R, Pérez-Arnal R, García-Gasulla D, Rodriguez A, Peñuelas O, Ángel Lorente J, Almansa R, Gabarrus A, Marin-Corral J, Ricart P, Roche-Campo F, Sancho Chinesta S, Socias L, Barbé F, Torres A; CIBERESUCICOVID Project (COV20/00110, ISCIII). Higher frequency of comorbidities in fully vaccinated patients admitted to ICU due to severe COVID-19: a prospective, multicenter, observational study. Eur Respir J 2021:2102275. [PMID: 34824059 DOI: 10.1183/13993003.02275-2021] [Reference Citation Analysis]
50 Singer J, Le NS, Mattes D, Klamminger V, Hackner K, Kolinsky N, Scherb M, Errhalt P, Kreye G, Pecherstorfer M, Vallet S, Podar K. Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients. Cancers (Basel) 2021;13:4312. [PMID: 34503127 DOI: 10.3390/cancers13174312] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Mitchell J, Alejo JL, Chiang TPY, Kim J, Chang A, Abedon AT, Avery RK, Tobian AAR, Massie AB, Levan ML, Warren DS, Garonzik-Wang JM, Segev DL, Werbel WA. Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update. Transplantation 2022. [PMID: 35426888 DOI: 10.1097/TP.0000000000004137] [Reference Citation Analysis]
52 Kute V, Meshram HS, Sharma A, Chaudhury AR, Sudhindran S, Gokhale AK, Hote M, Guleria R, Rana DS, Prakash J, Ramesh V. Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients. Transplant Proc 2021:S0041-1345(21)00683-7. [PMID: 34690000 DOI: 10.1016/j.transproceed.2021.09.007] [Reference Citation Analysis]
53 Ram R, Freund T, Halperin T, Ben-Ami R, Amit O, Bar-On Y, Beyar-Katz O, Eilaty N, Gold R, Kay S, Glait-Santar C, Hagin D. Immunogenicity of a third dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with impaired B cell reconstitution after cellular therapy - a Single Center Prospective Cohort Study. Transplant Cell Ther 2022:S2666-6367(22)00091-4. [PMID: 35182795 DOI: 10.1016/j.jtct.2022.02.012] [Reference Citation Analysis]
54 Shroff RT, Chalasani P, Wei R, Pennington D, Quirk G, Schoenle MV, Uhrlaub JL, Ripperger TJ, Jergović M, Dalgai S, Wolf A, Hammad H, Carrier A, Scott AJ, Nikolich-Žugich J, Worobey M, Sprissler R, Dake M, LaFleur BJ, Bhattacharya D. Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy. medRxiv 2021:2021. [PMID: 34013289 DOI: 10.1101/2021.05.13.21257129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
55 Hod T, Ben-David A, Olmer L, Scott N, Ghinea R, Mor E, Levy I, Indenbaum V, Lustig Y, Grossman E, Rahav G. BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients. Transpl Int 2022;35:10239. [PMID: 35387393 DOI: 10.3389/ti.2022.10239] [Reference Citation Analysis]
56 Prendecki M, Thomson T, Clarke CL, Martin P, Gleeson S, De Aguiar RC, Edwards H, Mortimer P, McIntyre S, Mokreri D, Cox A, Pickard G, Lightstone L, Thomas D, McAdoo SP, Kelleher P, Willicombe M; Imperial Renal COVID-19 vaccine study group in collaboration with the OCTAVE Study Consortium. Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients. Lancet 2021;398:1482-4. [PMID: 34619100 DOI: 10.1016/S0140-6736(21)02096-1] [Reference Citation Analysis]
57 Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect 2021:S1198-743X(21)00566-8. [PMID: 35020589 DOI: 10.1016/j.cmi.2021.09.036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kakos CD, Ziogas IA, Tsoulfas G. Pediatric transplantation during the COVID-19 pandemic. World J Transplant 2022; 12(5): 88-99 [DOI: 10.5500/wjt.v12.i5.88] [Reference Citation Analysis]
59 Matkowska-Kocjan A, Owoc-Lempach J, Chruszcz J, Kuźnik E, Szenborn F, Jurczenko L, Wójcik M, Banyś D, Szenborn L, Ussowicz M. The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation. Vaccines (Basel) 2021;9:1209. [PMID: 34696317 DOI: 10.3390/vaccines9101209] [Reference Citation Analysis]
60 Peck-Radosavljevic M, Burra P, Ferret MB, Fracasso P, Ricciardiello L, Seufferlein T, Van Hootegem P, van Leerdam M, Zelber-Sagi S; UEG Public Affairs Committee. COVID-19 and digestive health: Implications for prevention, care and the use of COVID-19 vaccines in vulnerable patients. United European Gastroenterol J 2021;9:1091-5. [PMID: 34716760 DOI: 10.1002/ueg2.12173] [Reference Citation Analysis]
61 Benotmane I, Gautier G, Perrin P, Olagne J, Cognard N, Fafi-Kremer S, Caillard S. Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. JAMA 2021. [PMID: 34297036 DOI: 10.1001/jama.2021.12339] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 51.0] [Reference Citation Analysis]
62 Sa-Nguanmoo N, Namdee K, Khongkow M, Ruktanonchai U, Zhao Y, Liang XJ. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Res 2021;:1-30. [PMID: 34659650 DOI: 10.1007/s12274-021-3832-y] [Reference Citation Analysis]
63 Sharma HN, Latimore COD, Matthews QL. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Pathogens 2021;10:1218. [PMID: 34578250 DOI: 10.3390/pathogens10091218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Marion O, Del Bello A, Abravanel F, Faguer S, Esposito L, Laure Hebral A, Bellière J, Izopet J, Kamar N. Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients. Transplant Direct 2022;8:e1248. [PMID: 34966837 DOI: 10.1097/TXD.0000000000001248] [Reference Citation Analysis]
65 Shapiro Ben David S, Shamir-Stein N, Baruch Gez S, Lerner U, Rahamim-Cohen D, Ekka Zohar A. Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey. Clin Immunol 2021;232:108860. [PMID: 34571262 DOI: 10.1016/j.clim.2021.108860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Ioannou GN, Locke ER, O'Hare AM, Bohnert ASB, Boyko EJ, Hynes DM, Berry K. COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System : A Target Trial Emulation Study. Ann Intern Med 2021. [PMID: 34928700 DOI: 10.7326/M21-3256] [Reference Citation Analysis]
67 Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, Eby Y, Ruff JE, Blankson JN, Abedon AT, Alejo JL, Cox AL, Bailey JR, Thompson EA, Klein SL, Warren DS, Garonzik-Wang JM, Boyarsky BJ, Sitaras I, Pekosz A, Segev DL, Tobian AAR, Werbel WA. A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients. medRxiv 2021:2021. [PMID: 34671774 DOI: 10.1101/2021.08.11.21261914] [Reference Citation Analysis]
68 Morawska M. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia. Eur J Haematol 2021. [PMID: 34717004 DOI: 10.1111/ejh.13722] [Reference Citation Analysis]
69 Van Oekelen O, Gleason CR, Agte S, Srivastava K, Beach KF, Aleman A, Kappes K, Mouhieddine TH, Wang B, Chari A, Cordon-Cardo C, Krammer F, Jagannath S, Simon V, Wajnberg A, Parekh S; PVI/Seronet team. Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell 2021;39:1028-30. [PMID: 34242572 DOI: 10.1016/j.ccell.2021.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
70 Redjoul R, Le Bouter A, Parinet V, Fourati S, Maury S. Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT. Lancet Haematol 2021;8:e681-3. [PMID: 34487683 DOI: 10.1016/S2352-3026(21)00274-X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
71 Diamantopoulos PT, Stafylidis C, Vlachopoulou D, Kontandreopoulou C, Giannakopoulou N, Vardaka M, Mpouhla A, Mastrogianni E, Variami E, Galanopoulos A, Pappa V, Psichogiou M, Hatzakis A, Viniou N. Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study. Therapeutic Advances in Hematology 2022;13:204062072210901. [DOI: 10.1177/20406207221090150] [Reference Citation Analysis]
72 Hebert SA. Renal Consequences of COVID-19. Methodist Debakey Cardiovasc J 2021;17:91-3. [PMID: 34992728 DOI: 10.14797/mdcvj.1058] [Reference Citation Analysis]
73 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Reference Citation Analysis]
74 Bernea L, Ailioaie OR, Benhamouda N, Tartour E, Germain DP. Humoral Immune Response to SARS-CoV-2 Vaccination after a Booster Vaccine Dose in Two Kidney Transplant Recipients with Fabry Disease and Variable Secondary Immunosuppressive Regimens. Vaccines (Basel) 2021;9:1412. [PMID: 34960158 DOI: 10.3390/vaccines9121412] [Reference Citation Analysis]
75 Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, Jabbour R, Hofbauer TM, Merrelaar A, Eder M, Regele F, Doberer K, Spechtl P, Aschauer C, Koblischke M, Paschen C, Eskandary F, Hu K, Öhler B, Bhandal A, Kleibenböck S, Jagoditsch RI, Reiskopf B, Heger F, Bond G, Böhmig GA, Strassl R, Weseslindtner L, Indra A, Aberle JH, Binder M, Oberbauer R. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial. JAMA Intern Med 2021. [PMID: 34928302 DOI: 10.1001/jamainternmed.2021.7372] [Reference Citation Analysis]
76 Aslam S, Ison MG. SARS-CoV-2 vaccination in heart transplantation: What we do and do not know. J Heart Lung Transplant 2021:S1053-2498(21)02573-0. [PMID: 34876356 DOI: 10.1016/j.healun.2021.10.017] [Reference Citation Analysis]
77 Li H, Yu J, Cao B. SARS-CoV-2 vaccination for immune-comprised patients: More is required. Lancet Reg Health Eur 2021;9:100191. [PMID: 34423326 DOI: 10.1016/j.lanepe.2021.100191] [Reference Citation Analysis]
78 Tamari R, Politikos I, Knorr DA, Vardhana SA, Young JC, Marcello LT, Doddi S, Devlin SM, Ramanathan LV, Pessin MS, Dunn E, Palazzo M, Bravo CD, Papanicolaou GA, Kamboj M, Perales MA, Chung DJ, Shah GL. Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy. Blood Cancer Discov 2021;2:577-85. [PMID: 34778798 DOI: 10.1158/2643-3230.BCD-21-0142] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Fathi A, Mellinghoff SC. [Vaccines against COVID-19]. Internist (Berl) 2021;62:1191-201. [PMID: 34613428 DOI: 10.1007/s00108-021-01164-0] [Reference Citation Analysis]
80 Marlet J, Gatault P, Maakaroun Z, Longuet H, Stefic K, Handala L, Eymieux S, Gyan E, Dartigeas C, Gaudy-Graffin C. Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia. Vaccines (Basel) 2021;9:1055. [PMID: 34696163 DOI: 10.3390/vaccines9101055] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Chivu-Economescu M, Bleotu C, Grancea C, Chiriac D, Botezatu A, Iancu IV, Pitica I, Necula LG, Neagu A, Matei L, Dragu D, Sultana C, Radu EL, Nastasie A, Voicu O, Ataman M, Nedeianu S, Mambet C, Diaconu CC, Ruta SM. Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19. J Cell Mol Med 2022. [PMID: 35043552 DOI: 10.1111/jcmm.17186] [Reference Citation Analysis]
82 Karaba AH, Johnston TS, Aytenfisu TY, Akinde O, Eby Y, Ruff JE, Abedon AT, Alejo JL, Blankson JN, Cox AL, Bailey JR, Klein SL, Pekosz A, Segev DL, Tobian AA, Werbel WA. A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004140] [Reference Citation Analysis]
83 Benning L, Klein K, Morath C, Bartenschlager M, Kim H, Buylaert M, Reineke M, Töllner M, Nusshag C, Kälble F, Reichel P, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Schaier M, Speer C. Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients. Front Immunol 2022;13:840136. [DOI: 10.3389/fimmu.2022.840136] [Reference Citation Analysis]
84 Chen T, Li X, Li Q, Huang L, Cai Q, Wang Y, Jiang Y, Xu Q, Lv Q, Wang J. COVID-19 vaccination hesitancy and associated factors among solid organ transplant recipients in China. Hum Vaccin Immunother 2021;:1-8. [PMID: 34586945 DOI: 10.1080/21645515.2021.1984133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Piñana JL, López-Corral L, Martino R, Montoro J, Vazquez L, Pérez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual MJ, Sanz-Linares G, Gago B, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave MT, López-Jimenez J, Marcos-Corrales S, García-Blázquez M, Garcia-Gutiérrez V, Hernández-Rivas JÁ, Saus A, Espigado I, Alonso C, Hernani R, Solano C, Ferrer-Lores B, Guerreiro M, Ruiz-García M, Muñoz-Bellido JL, Navarro D, Cedillo A, Sureda A; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol 2021. [PMID: 34695229 DOI: 10.1002/ajh.26385] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Guven DC, Sahin TK, Kilickap S, Uckun FM. Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review. Front Oncol 2021;11:759108. [PMID: 34804957 DOI: 10.3389/fonc.2021.759108] [Reference Citation Analysis]
87 Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity 2021;54:1636-51. [PMID: 34348117 DOI: 10.1016/j.immuni.2021.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
88 Kates OS. The right to bare arms. Transpl Infect Dis 2021;23:e13723. [PMID: 34494707 DOI: 10.1111/tid.13723] [Reference Citation Analysis]
89 Shaul AA, Itzhaki Ben Zadok O, Ben-Avraham B, Yaari V, Barsheshet A, Levi A, Ben Zvi H, Eliakim Raz N, Abed G, Abuhazira M, Abu Akel M, Mats I, Barac YD, Aravot D, Kornowski R, Ben-Gal T. Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients. Eur J Cardiothorac Surg 2022:ezac145. [PMID: 35244690 DOI: 10.1093/ejcts/ezac145] [Reference Citation Analysis]
90 Schrezenmeier E, Rincon-Arevalo H, Stefanski AL, Potekhin A, Staub-Hohenbleicher H, Choi M, Bachmann F, Pross V, Hammett C, Schrezenmeier H, Ludwig C, Jahrsdörfer B, Lino A, Eckardt KU, Kotsch K, Döerner T, Budde K, Sattler A, Halleck F. B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. J Am Soc Nephrol 2021:ASN. [PMID: 34667083 DOI: 10.1681/ASN.2021070966] [Reference Citation Analysis]
91 Crane C, Phebus E, Ingulli E. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients. Pediatr Nephrol 2021. [PMID: 34522992 DOI: 10.1007/s00467-021-05256-9] [Reference Citation Analysis]
92 Tanner R, Starr N, Chan G, Dempsey E, Heffernan E, Newman E, O'neill J, Hannan MM, Lynch B, Joyce E. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.01.005] [Reference Citation Analysis]
93 Akamine CM, El Sahly HM. Messenger Ribonucleic Acid Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2 - A Review. Transl Res 2021:S1931-5244(21)00304-2. [PMID: 34954088 DOI: 10.1016/j.trsl.2021.12.007] [Reference Citation Analysis]
94 Yang J, Ko JH, Baek JY, Hong J, Ha S, Lee B, Huh K, Cho SY, Kang CI, Chung DR, Kim YJ, Kang ES, Peck KR. Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine. Front Immunol 2021;12:744206. [PMID: 34630425 DOI: 10.3389/fimmu.2021.744206] [Reference Citation Analysis]